Skip to main content
Premium Trial:

Request an Annual Quote

Baypoint Bio Licenses Ovarian, Breast Cancer Dx IP from MD Anderson

NEW YORK (GenomeWeb News) – Baypoint Biosystems said today it has licensed predictive biomarker intellectual property from the University of Texas MD Anderson Cancer Center in Houston.

The privately held company has obtained exclusive, worldwide rights to commercialize certain proteomics IP and clinical biomarkers for predicting therapeutic responses for certain ovarian and breast cancers.

Baypoint Founder and CEO James Erickson said the proteomics technology will provide “our pharmaceutical partners with new insights into how their drugs are working, in which cancers their drugs are most likely to be effective, and how to rationally combine experimental drugs with approved therapeutics.”

Baypoint, which is also based in Houston, is developing predictive tests for ovarian cancer, hormone-dependent breast cancer, HER2-amplified breast cancer and triple receptor-negative breast cancer.

Financial terms of the agreement were not released.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.